Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
AMD (AMD) Delivers Record Revenue and Data Center Surge in Q2 2026

AMD (AMD) Delivers Record Revenue and Data Center Surge in Q2 2026

Key Takeaways

  • Revenue reached a record $11.54 billion, up 50% year-over-year and ahead of the $11.28 billion consensus estimate.
  • Non-GAAP earnings per share came in at $1.66, exceeding Wall Street's $1.62 forecast and reflecting an 82% comparable increase from the prior year.
  • Data center revenue more than doubled to $6.7 billion, driven by surging demand for EPYC server processors and Instinct AI accelerators, and now represents 58% of total company sales.
  • Third-quarter revenue guidance of approximately $13 billion topped the analyst consensus of $12.52 billion, but fell short of more aggressive buy-side expectations.
  • Shares dropped roughly 8-9% in after-hours trading despite the beat, as elevated investor expectations and a sharply higher capital expenditure figure weighed on sentiment.

The Buildup to AMD's Q2 Report

Advanced Micro Devices entered its second-quarter 2026 earnings report with enormous momentum. The stock had more than doubled year-to-date, riding a wave of optimism around artificial intelligence infrastructure spending and AMD's growing role as a credible challenger in the data center GPU market. Prior quarters had already demonstrated accelerating growth in the company's server CPU and AI accelerator businesses. This report was seen as a critical test of whether AMD's product roadmap — including the newly launched Helios rack-scale AI platform and sixth-generation EPYC Venice processors — could sustain the rapid expansion that investors had priced in. With the Philadelphia Semiconductor Index showing signs of fatigue after a historic rally, the stakes around this earnings release were unusually high. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.

What AMD Actually Delivered

AMD delivered second-quarter revenue of $11.54 billion, a 50% increase from $7.69 billion in the year-ago period and above the Bloomberg consensus estimate of $11.28 billion. On a GAAP basis, diluted earnings per share reached $1.38, compared to $0.54 a year earlier. On a non-GAAP basis, which excludes stock-based compensation, acquisition-related charges, and other items, earnings per share came in at $1.66, beating the consensus forecast of $1.62 and representing an approximately 82% comparable year-over-year increase.

The standout performer was the Data Center segment, where revenue surged 107% year-over-year to $6.7 billion. Within this segment, server CPU revenue grew more than 70% year-over-year, marking a fifth consecutive quarter of record server processor sales, while Instinct AI accelerator revenue also more than doubled. The Client and Gaming segment posted revenue of $3.8 billion, up 6% year-over-year, with client revenue rising 23% to $3.1 billion on strong Ryzen processor demand, partially offset by a 31% decline in gaming revenue to $779 million. The Embedded segment delivered its strongest growth in over three years, with revenue rising 19% to $977 million.

Non-GAAP gross margin expanded to 56%, up more than 200 basis points from the prior year, while non-GAAP operating income reached $3.1 billion, representing a 27% operating margin. For the third quarter, AMD guided revenue to approximately $13 billion, plus or minus $300 million, implying roughly 41% year-over-year growth at the midpoint and exceeding the analyst consensus of $12.52 billion. Non-GAAP gross margin is expected to remain at approximately 56%.

How the Market Reacted

Despite a clean beat on both revenue and earnings per share, AMD's stock experienced a sharp reversal in after-hours trading. Shares closed the regular session up 7% at $518.58, near the upper end of the stock's 52-week range, before falling approximately 8-9% to around the $472 level following the earnings release. The selloff underscored the challenge of meeting expectations that had been dramatically raised during the stock's 140%+ year-to-date run.

Two factors appeared to drive the negative after-hours reaction. First, while AMD's third-quarter revenue guidance of roughly $13 billion exceeded the published consensus of $12.52 billion, some Wall Street analysts and institutional investors had penciled in figures as high as $14 billion, leaving the official outlook short of the most optimistic scenarios. Second, capital expenditures came in at $808 million, nearly triple the approximately $299 million consensus estimate, signaling aggressive investment in AI infrastructure that may pressure near-term free cash flow. The pattern bore similarities to other chip-sector earnings this season, where beats alone proved insufficient to satisfy elevated investor expectations. From what I see, this highlights how sensitive the market has become to any gap versus the highest expectations.

Looking Ahead: What to Watch

Looking ahead, AMD enters the second half of 2026 with significant momentum in its core growth engines. CEO Lisa Su stated that the company expects data center segment revenue to more than double in 2027, with server CPU revenue projected to grow more than 70% year-over-year off a much higher base. The Helios rack-scale AI platform, which combines EPYC Venice CPUs, MI450-series GPUs, Pensando networking, and ROCm software, is now in production with initial shipments expected to begin later in the third quarter and ramp through the fourth quarter and into 2027.

Customer commitments provide a visible demand pipeline. AMD has announced multi-year AI infrastructure agreements with OpenAI, Meta, Anthropic, and Microsoft, with Anthropic planning to deploy up to 2 gigawatts of MI450-series GPUs in Helios systems beginning in the first half of 2027. These partnerships, while substantial, will need to translate into recognized revenue at the pace the market now expects.

Several factors warrant close monitoring in the quarters ahead. Supply chain conditions remain tight, particularly for server CPUs, though management expects the situation to improve in 2027 as additional capacity comes online. The PC market may soften in the second half as higher memory and component costs weigh on demand, though AMD expects its client business to outperform the broader market. Gaming revenue continues to contract as the console cycle matures, and the embedded segment's recovery, while encouraging, remains in its early stages. Perhaps most importantly, the pace and profitability of the Helios ramp will be decisive in determining whether AMD can deliver on the growth trajectory that its elevated valuation now demands. I'm watching this closely as the execution on these AI platforms unfolds.

Using Tickeron AI Tools in My Research

In my own process, I often turn to Tickeron's AI Screener when evaluating semiconductor names like AMD. It helps me quickly filter for comparable companies based on industry, technical patterns, and AI signals, giving a broader view beyond the headline numbers. This kind of data-driven screening has become a regular part of how I cross-check sector trends and spot relative strength or weakness before forming a fuller picture.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMD

AMD in upward trend: price rose above 50-day moving average on August 04, 2026

AMD moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend. In of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where AMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMD advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMD as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for AMD crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMD entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.123) is normal, around the industry mean (16.176). P/E Ratio (172.860) is within average values for comparable stocks, (238.937). Projected Growth (PEG Ratio) (1.215) is also within normal values, averaging (1.968). AMD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (22.727) is also within normal values, averaging (48.175).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 186.11B. The market cap for tickers in the group ranges from 13.43K to 5.13T. NVDA holds the highest valuation in this group at 5.13T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 12%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 53%. ALAB experienced the highest price growth at 39%, while NXPI experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 51
Price Growth Rating: 50
SMR Rating: 75
Profit Risk Rating: 73
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
AMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of integrated circuits for semiconductors

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
2485 Augustine Drive
Phone
+1 408 749-4000
Employees
31000
Web
https://www.amd.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.